Thus, patients not fulfilling RA criteria because they are efficiently treated at very early stages of the disease could behave as RA patients and still display high Gal1 at this last visit, whilst patients with other disorders may undergo Gal1 down-regulation once disease activity is controlled. The gene discussed is LGALS1; the disease is rheumatoid arthritis.